Literature DB >> 11350899

Cervical dysplasia, ploidy, and human papillomavirus status correlate with loss of Fhit expression.

A Vecchione1, N Zanesi, G Trombetta, D French, P Visca, T Pisani, C Botti, A Vecchione1, C M Croce, R Mancini.   

Abstract

PURPOSE: The tumor suppressor gene, FHIT, has been cloned and mapped at chromosome region 3p14.2, one of the regions most frequently deleted in cervical carcinoma. In this report, we show that the expression of the Fhit protein in relation to human papillomavirus (HPV) subtype, the type of the intraepithelial lesion, HIV-induced immunodeficiency, and the DNA content (ploidy) correlates with the biological behavior of the lesions. EXPERIMENTAL
DESIGN: To investigate involvement of the FHIT gene in squamous intraepithelial lesions of low and high grade (LGSILs and HGSILs, respectively) of the uterine cervix, we examined the Fhit protein expression by immunocytochemistry in 131 cervical smears of 96 HIV-seropositive patients (42 with LGSILs and 10 with HGSILs) and 35 HIV-seronegative (5 with LGSILs) persons.
RESULTS: Fhit protein was detected in normal cells, whereas dysplastic cells (independently of HPV infection and HPV subtypes) showed reduced expression of Fhit (P = 0.00001). Lesions from 52 HIV-seropositive patients, 42 LGSILs and 10 HGSILs, showed diploid DNA content in 63.5%, aneuploid in 32.7%, and polyploid in 3.8%, but 90% of the HGSILs showed an aneuploid DNA content, and all were infected by HPV 16/18 subtypes. 23.8% of LGSIL cases were associated with HPV 16.
CONCLUSIONS: These data clearly suggest that loss of Fhit expression occurs in the early stages of cervical carcinogenesis. Pap test represents one of the most convenient and rapid procedures available in identification of cellular changes; hence, Fhit staining might be used as an useful tool in larger population screening to detect early alteration in cellular behaviors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350899

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  4 in total

1.  Oncosuppressor proteins of fragile sites are reduced in cervical cancer.

Authors:  Enrico Giarnieri; Nicola Zanesi; Arianna Bottoni; Mauro Alderisio; Ankica Lukic; Aldo Vecchione; Vincenzo Ziparo; Carlo Maria Croce; Rita Mancini
Journal:  Cancer Lett       Date:  2009-08-22       Impact factor: 8.679

2.  Collecting duct carcinoma of the kidney: an immunohistochemical study of 11 cases.

Authors:  Andrea Vecchione; Tommaso Prayer Galetti; Marina Gardiman; Hideshi Ishii; Enrico Giarnieri; Francesco Pagano; Leonard G Gomella; Carlo M Croce; Raffaele Baffa
Journal:  BMC Urol       Date:  2004-09-09       Impact factor: 2.264

3.  The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions.

Authors:  G Terry; L Ho; P Londesborough; P Cross; A Lopes; J Monaghan; J Cuzick
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

4.  Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk.

Authors:  Yan Ding; Garrett Larson; Guillermo Rivas; Cathryn Lundberg; Louis Geller; Ching Ouyang; Jeffrey Weitzel; John Archambeau; Jerry Slater; Mary B Daly; Al B Benson; John M Kirkwood; Peter J O'Dwyer; Rebecca Sutphen; James A Stewart; David Johnson; Magnus Nordborg; Theodore G Krontiris
Journal:  PLoS One       Date:  2008-10-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.